U.S. pharma big copyright scrapped two experimental weight loss products final year—a after-each day capsule, lotiglipron, because of elevated liver enzymes and also a 2 times-every day capsule, danuglipron, resulting from powerful side effects—but CEO Albert Bourla has claimed the company is decided to “Enjoy and win” inside the obesity Ro